» Articles » PMID: 29959035

Selective Staining and Eradication of Cancer Cells by Protein-carrying DARPin-functionalized Liposomes

Overview
Specialty Pharmacology
Date 2018 Jul 1
PMID 29959035
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Since their discovery, liposomes have been widely employed in biomedical research. These nano-size spherical vesicles consisting one or few phospholipid bilayers surrounding an aqueous core are capable of carrying a wide variety of bioactive compounds, including drugs, peptides, nucleic acids, proteins and others. Despite considerable success achieved in synthesis of liposome constructs containing bioactive compounds, preparation of ligand-targeted liposomes comprising large quantities of encapsulated proteins that are capable of affecting pathological cells still remains a big challenge. Here we described a novel method for preparation of small (80-90 nm in diameter) unilamellar liposomes containing very large quantities (thousands of protein molecules per liposome) of heme-containing cytochrome c, highly fluorescent mCherry and highly toxic PE40 (Pseudomonas aeruginosa Exotoxin A domain). Efficient encapsulation of the proteins was achieved through electrostatic interaction between positively charged proteins (at pH lower than pI) and negatively charged liposome membrane. The proteoliposomes containing large quantities of mCherry or PE40 and functionalized with designed ankyrin repeat protein (DARPin)_9-29, which targets human epidermal growth factor receptor 2 (HER2) were shown to specifically stain and kill in sub-nanomolar concentrations HER2-positive cells, overexpressing HER2, respectively. Specific staining and eradication of the receptor-positive cells demonstrated here makes the DARPin-functionalized liposomes carrying large quantities of fluorescent and/or toxic proteins a promising candidate for tumor detection and therapy.

Citing Articles

A Vector Nanoplatform for the Bioimaging of Deep-Seated Tumors.

Shramova E, Deyev S, Proshkina G Acta Naturae. 2024; 16(2):72-81.

PMID: 39188260 PMC: 11345090. DOI: 10.32607/actanaturae.27425.


Immunoliposomes As a Promising Antiviral Agent against SARS-CoV-2.

Bobik T, Simonova M, Rushkevich N, Kostin N, Skryabin G, Knorre V Dokl Biochem Biophys. 2024; 514(1):6-10.

PMID: 38189883 PMC: 11021331. DOI: 10.1134/S1607672923700618.


Ultrasmall ATP-Coated Gold Nanoparticles Specifically Bind to Non-Hybridized Regions in DNA.

Katrivas L, Ben-Menachem A, Gupta S, Kotlyar A Nanomaterials (Basel). 2023; 13(24).

PMID: 38132978 PMC: 10745773. DOI: 10.3390/nano13243080.


Novel Small Multilamellar Liposomes Containing Large Quantities of Peptide Nucleic Acid Selectively Kill Breast Cancer Cells.

Proshkina G, Shramova E, Ryabova A, Katrivas L, Giannini C, Malpicci D Cancers (Basel). 2022; 14(19).

PMID: 36230729 PMC: 9564164. DOI: 10.3390/cancers14194806.


Artificial Scaffold Polypeptides As an Efficient Tool for the Targeted Delivery of Nanostructures In Vitro and In Vivo.

Shipunova V, Deyev S Acta Naturae. 2022; 14(1):54-72.

PMID: 35441046 PMC: 9013437. DOI: 10.32607/actanaturae.11545.